Tuberculosis and malaria in the age of COVID-19

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2021-08-25

Type Journal Article Author The Lancet Infectious Diseases URL https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30946-4/abstract Series Editorial Volume 21 Issue 1 Pages 1 Publication The Lancet Infectious Diseases ISSN 1473-3099, 1474-4457 Date 00/01/2021 Extra Publisher: Elsevier PMID: 33357386 Journal Abbr The Lancet Infectious Diseases DOI 10.1016/S1473-3099(20)30946-4 Library Catalog www.thelancet.com Language English Abstract With the world still focused on the COVID-19 pandemic and hopes for vaccine rollout, the 2020 WHO global reports on tuberculosis and malaria are timely reminders that these diseases remain two of the three deadliest infectious diseases. A key question in early 2020 was how the added strains of the pandemic on health-care systems would impact their management, with some dire early conjectures. So where are we now?